Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Is inhaled insulin delivery still a possibility? Why has it been a commercial failure?
EurekAlert, 09/24/09
The commercial failure of Exubera, the first inhaled insulin product to come to market, led other companies such as Eli Lilly–Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly–Alkermes decision to discontinue trials of the AIR inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Imaging cuts in Medicare fee schedule: An access catastrophe and danger to patients
EurekAlert, 11/03/09
To eat less, your body may want you to eat slowly
Reuters, 11/10/09
Daily dose of color may boost immunity this flu season
EurekAlert, 11/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


